Belgian pharma Mithra raises €72m through IPO
This article was originally published in Scrip
Executive Summary
Proving there is still investment promise for drug developers in the area of women's health, Belgium-based Mithra Pharmaceuticals has raised €72.3m (approximately $80m) via an initial public offering on Euronext Brussels.